Veytics Intelligence
2026-10-21 · NASDAQ

Alnylam Is Now Solidly Profitable. Why Are Investors Treating It Like a Broken Biotech?

Key PointsAlnylam's stock has plunged more than 40% this year, but the company's financials look great.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.